Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

NCT00109928

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente - Fremont Fremont, California, United States
  • Kaiser Permanente Medical Center - Hayward Hayward, California, United States
View all 77 locations
View Trial Details
Completed

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

NCT00357500

Conditions
Central Nervous System Neoplasms, Central Nervous System Tumor, Pediatric, Hematologic Diseases, +23 more
Locations
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Miami Children's Hospital Miami, Florida, United States
  • Children's Memorial Hospital - Chicago Chicago, Illinois, United States
  • Maine Medical Center Research Institute Scarborough, Maine, United States
View Trial Details
Completed

Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma

NCT00059839

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 159 locations
View Trial Details
Completed

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

NCT01309737

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
  • Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States
  • University of California San Diego La Jolla, California, United States
View all 94 locations
View Trial Details
Completed

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

NCT01276639

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
Locations
  • Radiant Research, Inc. Birmingham, Alabama, United States
  • University of California, Irvine - Dermatology Research Irvine, California, United States
  • Skin Surgery Medical Group, Inc. San Diego, California, United States
  • Clinical Science Institute Santa Monica, California, United States
View all 74 locations
View Trial Details

Related conditions